Anthracycline dose and liver dysfunction

le Cannizzaro, R, Crivellari, D, Robieux, I, Sorio, R, Buonadonna, A
Foilsithe 1999

Adjuvant! Online or comprehensive geriatric assessment for women over 70 years with primary breast cancer?

le Monfardini, S, Basso, U, Fiduccia, P, Crivellari, D, Molino, A M, Falci, C
Foilsithe 2012

Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer...

le Muraro, E, Comaro, E, Talamini, R, Turchet, E, Miolo, G, Scalone, S, Militello, L, Lombardi, D, Spazzapan, S, Perin, T, Massarut, S, Crivellari, D, Dolcetti, Riccardo, Martorelli, D
Foilsithe in J Transl Med (2015)

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report

le Karlsson, P., Cole, B. F., Chua, B. H., Price, K. N., Lindtner, J., Collins, J. P., Kovács, A., Thürlimann, B., Crivellari, D., Castiglione-Gertsch, M., Forbes, J. F., Gelber, R. D., Goldhirsch, A., Gruber, G.
Foilsithe 2012

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

le Aebi, S., Sun, Z., Braun, D., Price, K. N., Castiglione-Gertsch, M., Rabaglio, M., Gelber, R. D., Crivellari, D., Lindtner, J., Snyder, R., Karlsson, P., Simoncini, E., Gusterson, B. A., Viale, G., Regan, M. M., Coates, A. S., Goldhirsch, A.
Foilsithe 2011

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with nod...

le Karlsson, P., Sun, Z., Braun, D., Price, K. N., Castiglione-Gertsch, M., Rabaglio, M., Gelber, R. D., Crivellari, D., Collins, J., Murray, E., Zaman, K., Colleoni, M., Gusterson, B. A., Viale, G., Regan, M. M., Coates, A. S., Goldhirsch, A.
Foilsithe 2011

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer

le Gruber, G., Cole, B. F., Castiglione-Gertsch, M., Holmberg, S. B., Lindtner, J., Golouh, R., Collins, J., Crivellari, D., Thürlimann, B., Simoncini, E., Fey, M. F., Gelber, R. D., Coates, A. S., Price, K. N., Goldhirsch, A., Viale, G., Gusterson, B. A.
Foilsithe 2008

Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

le Bernhard, J, Zahrieh, D, Coates, A S, Gelber, R D, Castiglione-Gertsch, M, Murray, E, Forbes, J F, Perey, L, Collins, J, Snyder, R, Rudenstam, C-M, Crivellari, D, Veronesi, A, Thürlimann, B, Fey, M F, Price, K N, Goldhirsch, A, Hürny, C
Foilsithe 2004

Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF

le Colleoni, M, Litman, H J, Castiglione-Gertsch, M, Sauerbrei, W, Gelber, R D, Bonetti, M, Coates, A S, Schumacher, M, Bastert, G, Rudenstam, C-M, Schmoor, C, Lindtner, J, Collins, J, Thürlimann, B, Holmberg, S B, Crivellari, D, Beyerle, C, Neumann, R L A, Goldhirsch, A
Foilsithe 2002

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomiz...

le Viale, G., Giobbie-Hurder, A., Gusterson, B. A., Maiorano, E., Mastropasqua, M. G., Sonzogni, A., Mallon, E., Colleoni, M., Castiglione-Gertsch, M., Regan, M. M., Price, K. N., Brown, R. W., Golouh, R., Crivellari, D., Karlsson, P., Öhlschlegel, C., Gelber, R. D., Goldhirsch, A., Coates, A. S.
Foilsithe 2010